Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: Interrupted time series evaluation of effectiveness

被引:49
作者
Harris A.H.S. [1 ]
Bowe T. [1 ]
Hagedorn H. [2 ]
Nevedal A. [1 ]
Finlay A.K. [1 ]
Gidwani R. [1 ]
Rosen C. [1 ]
Kay C. [3 ]
Christopher M. [3 ]
机构
[1] Center for Innovation to Implementation, Health Services Research and Development, VA Palo Alto Health Care System, Menlo Park, CA
[2] Center for Chronic Disease Outcomes Research, Health Services Research and Development, VA Minneapolis Health Care System, Minneapolis, MN
[3] Pharmacy Benefits Management, Academic Detailing Program, VA San Diego Health Care System, San Diego, CA
关键词
Alcohol use disorder; Guideline adherence; Implementation; Medication assisted treatment; Pharmacotherapy; Practice guidelines; Quality improvement;
D O I
10.1186/s13722-016-0063-8
中图分类号
学科分类号
摘要
Background: Active consideration of effective medications to treat alcohol use disorder (AUD) is a consensus standard of care, yet knowledge and use of these medications are very low across diverse settings. This study evaluated the overall effectiveness a multifaceted academic detailing program to address this persistent quality problem in the US Veterans Health Administration (VHA), as well as the context and process factors that explained variation in effectiveness across sites. Methods: An interrupted time series design, analyzed with mixed-effects segmented logistic regression, was used to evaluate changes in level and rate of change in the monthly percent of patients with a clinically documented AUD who received naltrexone, acamprosate, disulfiram, or topiramate. Using data from a 20 month post-implementation period, intervention sites (n = 37) were compared to their own 16 month pre-implementation performance and separately to the rest of VHA. Results: From immediately pre-intervention to the end of the observation period, the percent of patients in the intervention sites with AUD who received medication increased over 3.4 % in absolute terms and 68 % in relative terms (i.e., 4.9-8.3 %). This change was significant compared to the pre-implementation period in the intervention sites and secular trends in control sites. Sites with lower pre-implementation adoption, more person hours of detailing, but fewer people detailed, had larger immediate increases in medication receipt after implementation. The average number of detailing encounters per person was associated with steeper increases in slope over time. Conclusions: This study found empirical support for a multifaceted quality improvement strategy aimed at increasing access to and utilization of pharmacotherapy for AUD. Future studies should focus on determining how to enhance the programs effects, especially in non-responsive locations. © 2016 The Author(s).
引用
收藏
相关论文
共 23 条
[1]  
Blodgett J.C., Del Re A.C., Maisel N.C., Et al., A meta-analysis of topiramate's effects for individuals with alcohol use disorders, Alcohol Clin Exp Res, 38, pp. 1481-1488, (2014)
[2]  
Maisel N.C., Blodgett J.C., Wilbourne P.L., Et al., Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: When are these medications most helpful?, Addiction, 108, pp. 275-293, (2013)
[3]  
Jonas D.E., Amick H.R., Feltner C., Et al., Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis, JAMA, 311, pp. 1889-1900, (2014)
[4]  
Magill M., Ray L.A., Cognitive-behavioral treatment with adult alcohol and illicit drug users: A meta-analysis of randomized controlled trials, J Stud Alcohol Drugs, 70, pp. 516-527, (2009)
[5]  
Riper H., Andersson G., Hunter S.B., Et al., Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: A meta-analysis, Addiction, 109, pp. 394-406, (2014)
[6]  
Alcohol Facts and Statistics, (2015)
[7]  
Ducharme L.J., Chandler R.K., Harris A.H.S., Implementing substance abuse treatment in general medical settings: Mapping the research terrain, J Subst Abuse Treat, 60, pp. 110-118, (2016)
[8]  
Harris A.H., Ellerbe L., Reeder R.N., Et al., Pharmacotherapy for alcohol dependence: Perceived treatment barriers and action strategies among Veterans Health Administration service providers, Psychol Serv, 10, pp. 410-419, (2013)
[9]  
Harris A.H., Kivlahan D.R., Bowe T., Et al., Pharmacotherapy of alcohol use disorders in the Veterans Health Administration, Psychiatr Serv, 61, pp. 392-398, (2010)
[10]  
Mark T.L., Kassed C.A., Vandivort-Warren R., Et al., Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty, Drug Alcohol Depend, 99, pp. 345-349, (2009)